119 related articles for article (PubMed ID: 33851736)
1. Prevalence of high-risk HPV and its genotypes-Implications in the choice of prophylactic HPV vaccine.
Suresh A; Suresh P; Biswas R; Rajanbabu A; Sreedhar S; Biswas L
J Med Virol; 2021 Aug; 93(8):5188-5192. PubMed ID: 33851736
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe: epidemiological implication for vaccination against human papillomavirus.
Konopnicki D; Manigart Y; Gilles C; Barlow P; De Marchin J; Feoli F; Delforge M; Clumeck N; De Wit S
AIDS; 2016 Jan; 30(3):425-33. PubMed ID: 26765936
[TBL] [Abstract][Full Text] [Related]
3. Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
Perez S; Iñarrea A; Pérez-Tanoira R; Gil M; López-Díez E; Valenzuela O; Porto M; Alberte-Lista L; Peteiro-Cancelo MA; Treinta A; Carballo R; Reboredo MC; Alvarez-Argüelles ME; Purriños MJ
Virol J; 2017 Nov; 14(1):214. PubMed ID: 29110680
[TBL] [Abstract][Full Text] [Related]
4. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India.
Senapati R; Nayak B; Kar SK; Dwibedi B
BMC Infect Dis; 2017 Jan; 17(1):30. PubMed ID: 28056826
[TBL] [Abstract][Full Text] [Related]
5. Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine.
Godi A; Bissett SL; Miller E; Beddows S
PLoS One; 2015; 10(10):e0140926. PubMed ID: 26495976
[TBL] [Abstract][Full Text] [Related]
6. Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines.
Ahmed AI; Bissett SL; Beddows S
Infect Genet Evol; 2013 Aug; 18():151-9. PubMed ID: 23722024
[TBL] [Abstract][Full Text] [Related]
7. UK population based study to predict impact of HPV vaccination.
Hibbitts S; Tristram A; Beer H; McRea J; Rose B; Hauke A; Nuttall D; Dallimore N; Newcombe RG; Fiander A
J Clin Virol; 2014 Feb; 59(2):109-14. PubMed ID: 24388208
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human papillomavirus infection and genotype distribution among high-risk Korean women for prospecting the strategy of vaccine development.
Rhee JE; Shin MY; Kim CM; Kee HY; Chung JK; Min SK; Kim SJ; Jang DH; Kim SS; Choi BS
Virol J; 2010 Aug; 7():201. PubMed ID: 20738861
[TBL] [Abstract][Full Text] [Related]
9. HPV prevalence and genotype distribution among women in Shandong Province, China: Analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory.
Jiang L; Tian X; Peng D; Zhang L; Xie F; Bi C; Wang R; Wang J; Qi D
PLoS One; 2019; 14(1):e0210311. PubMed ID: 30653566
[TBL] [Abstract][Full Text] [Related]
10. A Study of Human Papillomavirus Genotypes Specificity and the Vaccines Introducing System for Korean-Chinese Women in the Yanbian Autonomous Region.
Wu Q; Kuk JH; Ryu YJ
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3331-3338. PubMed ID: 33247692
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two PCR-based human papillomavirus genotyping methods.
Castle PE; Porras C; Quint WG; Rodriguez AC; Schiffman M; Gravitt PE; González P; Katki HA; Silva S; Freer E; Van Doorn LJ; Jiménez S; Herrero R; Hildesheim A;
J Clin Microbiol; 2008 Oct; 46(10):3437-45. PubMed ID: 18716224
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of human papillomavirus types and phylogenetic analysis of HPV-16 L1 variants from Southern India.
Kabekkodu SP; Bhat S; Pandey D; Varghese VK; Shukla V; Ghosh S; Kushtagi P; Bhat P; Gopinath PM; Satyamoorthy K
Asian Pac J Cancer Prev; 2015; 16(5):2073-80. PubMed ID: 25773853
[TBL] [Abstract][Full Text] [Related]
13. Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.
Woestenberg PJ; King AJ; van Benthem BHB; Donken R; Leussink S; van der Klis FRM; de Melker HE; van der Sande MAB; Hoebe CJPA; Bogaards JA;
J Infect Dis; 2018 Jan; 217(2):213-222. PubMed ID: 29140439
[TBL] [Abstract][Full Text] [Related]
14. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
15. Human papillomavirus infection in females with normal cervical cytology: Genotyping and phylogenetic analysis among women in Punjab, Pakistan.
Aziz H; Iqbal H; Mahmood H; Fatima S; Faheem M; Sattar AA; Tabassum S; Napper S; Batool S; Rasheed N
Int J Infect Dis; 2018 Jan; 66():83-89. PubMed ID: 29138009
[TBL] [Abstract][Full Text] [Related]
16. Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine.
Godi A; Panwar K; Haque M; Cocuzza CE; Andrews N; Southern J; Turner P; Miller E; Beddows S
Vaccine; 2019 Apr; 37(18):2455-2462. PubMed ID: 30926298
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes.
Barzon L; Squarzon L; Masiero S; Pacenti M; Marcati G; Mantelli B; Gabrielli L; Pascucci MG; Lazzarotto T; Caputo A; Palù G
Vaccine; 2014 Sep; 32(41):5357-62. PubMed ID: 25045814
[TBL] [Abstract][Full Text] [Related]
18. Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin, on the coast of eastern China.
Lu JF; Shen GR; Li Q; Chen X; Ma CF; Zhu TH
BMC Infect Dis; 2017 Mar; 17(1):226. PubMed ID: 28335818
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
20. An anal cancer screening program for MSM in Italy: Prevalence of multiple HPV types and vaccine-targeted infections.
Garbuglia AR; Gentile M; Del Nonno F; Lorenzini P; Lapa D; Lupi F; Pinnetti C; Baiocchini A; Libertone R; Cicalini S; Capobianchi MR; Ammassari A
J Clin Virol; 2015 Nov; 72():49-54. PubMed ID: 26397204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
